This was the stock's third consecutive day of losses.

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

Boston Scientific (BSX) closed the most recent trading day at $98.50, moving -1.55% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. On ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Boston Scientific plans to break ground soon on a major expansion in Maple Grove, a project that’s up for $1.66 million in ...

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

Looking into the current session, Boston Scientific Inc. BSX shares are trading at $96.89, after a 3.16% drop. Over the past month, the stock fell by 1.95%, but over the past year ...

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging ...

MARLBOROUGH, Mass., April 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first ...

This was the stock's second consecutive day of losses.